Intelligence Platform
Patents
Browse 19 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination wi
granted patentUS 12076324
Cancer treatments using combinations of CDK and ERK inhibitors
granted patentUS 11679112
Cancer treatments using combinations of CDK and ERK inhibitors
granted patentUS 11439669
C. novyi for the treatment of solid tumors in humans
granted patentUS 11246859
Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers
granted patentUS 11135225
Cancer treatments using combinations of CDK and ERK inhibitors
granted patentUS 11033537
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted patentUS 11013743
Cancer treatments using combinations of CDK and ERK inhibitors
granted patentUS 11007183
Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors
granted patentUS 11007184
Cancer treatments using combinations of type 2 MEK and ERK inhibitors
granted patentUS 10881646
Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers
granted patentUS 10716782
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted patentUS 10668055
Cancer treatment using combinations of ERK and RAF inhibitors
granted patentUS 10617723
C. novyi for the treatment of solid tumors in humans
granted patentUS 10485796
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted patentUS 9951041
Crystalline C21H22Cl2N4O2 malonate
granted patentUS 9861621
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted patentUS 9757424
Compositions and methods of treating gliomas
granted patentUS 9670177
Crystalline C21H22Cl2N4O2 malonate
granted